MU-TYPE
MOLECULAR TARGETMu-type opioid receptor (human)
MU-TYPE (Mu-type opioid receptor (human)) is targeted by 65 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MU-TYPE
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 65 compounds. Use the BiohacksAI search to explore all MU-TYPE modulators.
About MU-TYPE as a Drug Target
MU-TYPE (Mu-type opioid receptor (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 65 compounds with documented MU-TYPE interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MU-TYPE inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.